Marksans Pharma Limited (NSE:MARKSANS)
India
· Delayed Price · Currency is INR 251.95
-5.90 (-2.29%)
Jun 6, 2025, 3:29 PM IST
Marksans Pharma Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 6, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Market Capitalization | 114,175 | 100,815 | 68,836 | 31,903 | 18,627 | 20,445 | Upgrade
|
| Market Cap Growth | 46.46% | 46.46% | 115.77% | 71.27% | -8.89% | 259.35% | Upgrade
|
| Enterprise Value | 110,569 | 96,315 | 63,549 | 29,746 | 16,052 | 19,467 | Upgrade
|
| Last Close Price | 251.95 | 222.47 | 151.59 | 69.86 | 44.94 | 49.16 | Upgrade
|
| PE Ratio | 29.99 | 26.49 | 21.94 | 11.98 | 9.97 | 8.57 | Upgrade
|
| Forward PE | 23.44 | 5.39 | 5.39 | 5.39 | 5.39 | 5.39 | Upgrade
|
| PS Ratio | 4.35 | 3.84 | 3.16 | 1.72 | 1.25 | 1.49 | Upgrade
|
| PB Ratio | 4.59 | 4.05 | 3.30 | 1.81 | 1.52 | 2.26 | Upgrade
|
| P/TBV Ratio | 4.85 | 4.28 | 3.51 | 1.95 | 1.67 | 2.50 | Upgrade
|
| P/FCF Ratio | 338.35 | 298.76 | 319.14 | 17.36 | 35.20 | 15.47 | Upgrade
|
| P/OCF Ratio | 55.25 | 48.78 | 29.88 | 13.44 | 18.77 | 11.45 | Upgrade
|
| PEG Ratio | - | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | Upgrade
|
| EV/Sales Ratio | 4.22 | 3.67 | 2.92 | 1.61 | 1.08 | 1.42 | Upgrade
|
| EV/EBITDA Ratio | 20.92 | 18.22 | 14.65 | 9.29 | 6.68 | 5.81 | Upgrade
|
| EV/EBIT Ratio | 24.83 | 21.63 | 16.54 | 10.34 | 7.50 | 6.30 | Upgrade
|
| EV/FCF Ratio | 327.66 | 285.42 | 294.63 | 16.19 | 30.33 | 14.73 | Upgrade
|
| Debt / Equity Ratio | 0.13 | 0.13 | 0.12 | 0.07 | 0.09 | 0.04 | Upgrade
|
| Debt / EBITDA Ratio | 0.61 | 0.61 | 0.53 | 0.36 | 0.43 | 0.12 | Upgrade
|
| Debt / FCF Ratio | 9.54 | 9.54 | 11.32 | 0.67 | 2.09 | 0.30 | Upgrade
|
| Asset Turnover | 0.89 | 0.89 | 0.89 | 0.97 | 1.04 | 1.29 | Upgrade
|
| Inventory Turnover | 1.56 | 1.56 | 1.94 | 2.07 | 1.76 | 1.87 | Upgrade
|
| Quick Ratio | 2.63 | 2.63 | 2.99 | 3.34 | 2.09 | 1.62 | Upgrade
|
| Current Ratio | 4.62 | 4.62 | 4.78 | 4.91 | 3.37 | 3.02 | Upgrade
|
| Return on Equity (ROE) | 16.73% | 16.73% | 16.35% | 17.76% | 17.55% | 30.69% | Upgrade
|
| Return on Assets (ROA) | 9.40% | 9.40% | 9.86% | 9.39% | 9.33% | 18.13% | Upgrade
|
| Return on Capital (ROIC) | 10.82% | 10.82% | 11.39% | 11.16% | 11.75% | 23.74% | Upgrade
|
| Return on Capital Employed (ROCE) | 16.10% | 16.10% | 16.80% | 15.60% | 16.70% | 33.30% | Upgrade
|
| Earnings Yield | 3.33% | 3.77% | 4.56% | 8.35% | 10.03% | 11.67% | Upgrade
|
| FCF Yield | 0.30% | 0.34% | 0.31% | 5.76% | 2.84% | 6.46% | Upgrade
|
| Dividend Yield | 0.31% | 0.36% | 0.40% | 0.72% | 0.56% | 0.51% | Upgrade
|
| Payout Ratio | 7.14% | 7.14% | 7.22% | 3.82% | 5.67% | 1.72% | Upgrade
|
| Buyback Yield / Dilution | 0.02% | 0.02% | -9.09% | -1.49% | - | 0.00% | Upgrade
|
| Total Shareholder Return | 0.33% | 0.38% | -8.69% | -0.77% | 0.56% | 0.51% | Upgrade
|
Updated Feb 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.